Accenture Announces Collaboration with Bayer to Streamline Drug Development Processes through INTIENT Clinical Platform

NEW YORK; Sept. 16, 2019 – Accenture (NYSE: ACN) has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which went live at Bayer earlier this year, brings internal and external clinical data together with Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve patient outcomes.

Comments

Popular posts from this blog

Add Custom Field in Output of Standard Report of ME2N

UK to Receive Egyptian LNG Cargo

HANA Housekeeping using HANACleaner